KMT2A and Wiedemann-Steiner syndrome: The molecular function of KMT2A in catalyzing H3K4me3 and promoting gene activation is shared across many tissues, and yet its disruption is felt most prominently in the brain, with loss-of-function mutations in KMT2A causing the chromatinopathy disorder Wiedemann-Steiner Syndrome (WSS)29,30.